IndiTreat® is a family of IVD tests developed and run by 2cureX as an aid to predict cancer patient’s response and resistance to different drug regimens. The tests assess the effect of exposing patient-derived 3D tumoroids in vitro to various drugs and drug combinations.

As a result, IndiTreat® enables treating physician to design a truly personalized treatment for each patient.

PRECISION ONCOLOGY FOR ALL CANCER PATIENTS